Stockholm, April 7, 2011 — NASDAQ OMX (NASDAQ: NDAQ) announces that trading in Pledpharma AB (short name: PLED) shares will commence today, April 7, on First North at NASDAQ OMX Stockholm. Pledpharma belongs to the Health Care sector.
Pledpharma develops therapies for severe diseases. By streamlining the different treatments the company's drugs are designed to reduce serious side effects while increasing patient survival rates. Pledpharma currently has two projects in clinical Phase II, one in the cancer field and one in the cardiovascular field. For more information see www.pledpharma.se.
Jenny Rosberg, Senior Vice President at NASDAQ OMX said, “We are pleased that Pledpharma chose to list at First North, one of Europe’s most liquid growth markets, where they will make a great addition to our healthcare sector. We continue to see a steady listing inflow to First North and welcome more companies to take advantage of the investor visibility and reach that we can offer.”
Pledpharma’s CEO, Jacques Näsström, commented, “Today marks an exciting day for our company and we look forward to benefiting from the increased investor exposure at First North. Pledpharma operates in a market with tremendous potential, and on First North we are able to build the capital strength needed to support continued and organic growth.”
Pledpharma has appointed Erik Penser Aktiebolag as Certified Advisor.
- # -
About First North
First North is regulated as a multilateral trading facility, operated by the different exchanges within NASDAQ OMX Nordic. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
About NASDAQ OMX
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with approximately 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook (http://www.facebook.com/nasdaqomx) and Twitter (http://www.twitter.com/nasdaqomx).
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
NASDAQ OMX Media contact:
Carl Norell +46 8 405 6639
carl.norell@nasdaqomx.com
